Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)-Reference-Cited by-同舟云学术

Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)

Published:2017 Issue:1 Volume:2 Page:e000147
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Salvatore Lisa,Aprile Giuseppe,Arnoldi Ermenegildo,Aschele Carlo,Carnaghi Carlo,Cosimelli Maurizio,Maiello Evaristo,Normanno Nicola,Sciallero Stefania,Valvo Francesca,Beretta Giordano D.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference70 articles.

1. CHKöhne, RHofheinz, LMineur, et al. I numeri del cancro in italia—2016. http://www.registri-tumori.it/cms/it/node/4572.

2. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition—professional requirements and training;Steele;Endoscopy,2012

3. Policy statement on multidisciplinary cancer care;Borras;Eur J Cancer,2014

4. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women;Kesson;BMJ,2012

5. Mutations of KRAS and BRAF in primary and matched metastatic sites of colorectal cancer;Artale;J Clin Oncol,2008

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced postoperative mobilization and biotracking after colorectal oncological resection (INTENSE) – study protocol for a randomized controlled trial;2024-05-20

2. Dynamic ctDNA-based analysis of drug-resistant gene alterations at RAS/BRAF wild-type metastatic colorectal cancer patients after cetuximab plus chemotherapy as the first-line treatment;International Immunopharmacology;2024-04

3. Colorectal cancer treatment guidelines and shared decision making quality and reporting assessment: Systematic review;Patient Education and Counseling;2023-10

4. 3-Bromopyruvate overcomes cetuximab resistance in human colorectal cancer cells by inducing autophagy-dependent ferroptosis;Cancer Gene Therapy;2023-08-09

5. TP5: A Novel Therapeutic Approach Targeting Aberrant and Hyperactive CDK5/p25 for the Treatment of Colorectal Carcinoma;International Journal of Molecular Sciences;2023-07-21